Valendo Health

As we provide Endocrinologists with the tools and support needed to grow their practice and shape the future of diabetes care, we are honored to collaborate with industry thought leaders in our newly formed strategic advisory board. We are thrilled to welcome the following members to the Valendo Health Advisory Board.

‍

Robert Gabbay, MD, PhD, is Chief Scientific and Medical Officer of the American Diabetes Association and Associate Professor at Harvard Medical School. His research focuses on innovative models of diabetes care to improve diabetes outcomes and the lives of people with diabetes. Throughout his impressive career he has had many accomplishments as a basic science researcher, developer of patient communication tools, creator of the first broad scale diabetes registry, designer of care management training programs, and leader of one of the largest primary care transformation efforts in the US around the Patient Centered Medical Home.

Claudia Graham, Phd, MPH, is the former Senior Vice President of Global Access at Dexcom, where she navigated the complexities of the US Medicare and healthcare systems, using health economics, outcomes research and coding to define a strategy for reimbursement. She also made significant inroads to improving access for diabetes technologies for patients and physicians domestically and internationally.

‍

‍William Biggs, MD, FACE, ECNU was one of the first physicians in the country to be board certified in the new specialty of Clinical Informatics in 2013. He is the CEO and Medical Director for the Amarillo Legacy Medical ACO, which works to improve healthcare in Amarillo by better communication and collaboration among providers, and use of informatics tools to improve health care delivery. Dr. Biggs speaks at conferences nationwide on population health, and how Amarillo has successfully implemented tools to provide better health at lower cost.

‍‍

‍David Bleich, M.D. is Chief of Endocrinology, Diabetes, Metabolism and Professor of Medicine at Rutgers New Jersey Medical School. For years he conducted basic science research in the field of pancreatic beta cell function and Type 1 diabetes, but has since transitioned to clinical endocrinology and diabetes. He has served as Chairman of national and local diabetes grant review committees, and has held leadership positions in the American Diabetes Association and the American Association of Clinical Endocrinology.

‍

‍Reza Yavari, M.D., Reza Yavari M.D. is a Yale-trained Board-Certified Endocrinologist with over two decades of medical practice focused on diabetes, obesity, and therapeutic lifestyle change. He is the author of several books and many articles and has been active in teaching and lecturing to a variety of audiences nationwide.

‍

Reza Alavi, M.D., MHS, MBA, is the Principal Co Founder of Quintuple Aim Solutions, Dr. Alavi partners with startups to accelerate their journey towards value-based care through GTM strategy, product market fit optimization, risk-based contracting, and commercialization support. He served as the Chief Clinical Officer of Dispatch Health, and the President of their Advanced Care business unit in 2022.

‍

Valendo Health is grateful to our new advisory board members and looks forward to leveraging their varied experience to help us navigate the world of Endocrinology and help serve those living with diabetes at the highest level.

‍

Thank you!

David Weingard, Chief Strategy Officer

davidw@valendohealth.com

‍

Read More:

Introducing Valendo Health

Valendo Health Announces Strategic Advisory Board